Form 4 for PFE Pfizer
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001225208-25-002709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | 2025-02-27 | PFE | BOSHOFF CHRISTOFFEL | Pres, R, D | F - Tax | $26.10 | -8,909 | 163.2K | -5% | -$232.5K | |
| 2025-03-03 | 2025-02-27 | PFE | BOSHOFF CHRISTOFFEL | Pres, R, D | A - Grant | $0.00 | +17.4K | 172.1K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-27 | F | D | 8,909 | $26.10 | 163,238 | D | — | — | (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon). |
| 2 | Common | Common Stock | 2025-02-27 | A | A | 17,450 | $0.00 | 172,147 | D | — | — | (F1) The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon). |